Fluoranthene

Fluoranthene

SCHEMBL6422146

CN1c2ccccc2Sc2ccccc21.c1ccc2c(c1)-c1cccc3cccc-2c13

nearest known ligand 0.66

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOA P21397 1/20 0.66
▸ ALDH1A1 P00352 5/20 0.52
▸ L3MBTL1 Q9Y468 3/20 0.52
▸ MAPK1 P28482 3/20 0.52
▸ HSD17B10 Q99714 3/20 0.52
▸ TSHR P16473 2/20 0.52
▸ ATM Q13315 1/20 0.52
▸ NOX1 Q9Y5S8 6/20 0.50
▸ MEN1 O00255 3/20 0.50
▸ KMT2A Q03164 3/20 0.50
▸ ADRA2A P08913 1/20 0.50
▸ ADRA2B P18089 1/20 0.50
▸ ADRA2C P18825 1/20 0.50
▸ CHRM3 P20309 1/20 0.50
▸ SLC6A2 P23975 1/20 0.50
▸ HTR2C P28335 1/20 0.50
▸ SLC6A4 P31645 1/20 0.50
▸ DRD3 P35462 1/20 0.50
▸ HTR2B P41595 1/20 0.50
▸ MAPT P10636 4/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29377505 0.81 MAOA (1.00) MAOAALDH1A1L3MBTL1MAPK1TSHR
SCHEMBL231247 0.81 MAOA (1.00) MAOAALDH1A1L3MBTL1MAPK1TSHR
SCHEMBL25474107 0.80 MAOA (0.73) MAOAALDH1A1L3MBTL1MAPK1TSHR
SCHEMBL12258292 0.76 ALDH1A1 (0.59) ALDH1A1L3MBTL1MAPK1HSD17B10TSHR
SCHEMBL12793430 0.75 MAOA (0.70) MAOAALDH1A1L3MBTL1MAPK1TSHR
Fluoranthene SCHEMBL8873541 0.72 ALDH1A1 (1.00) ALDH1A1L3MBTL1MAPK1HSD17B10TSHR
Fluoranthene SCHEMBL29355720 0.72 ALDH1A1 (1.00) ALDH1A1L3MBTL1MAPK1HSD17B10TSHR
SCHEMBL23525587 0.72 ALDH1A1 (1.00) ALDH1A1L3MBTL1MAPK1HSD17B10TSHR
Fluoranthene SCHEMBL29396242 0.72 ALDH1A1 (1.00) ALDH1A1L3MBTL1MAPK1HSD17B10TSHR
Fluoranthene SCHEMBL27152 0.72 ALDH1A1 (1.00) ALDH1A1L3MBTL1MAPK1HSD17B10TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050181443-A1 Coreactant-including electrochemiluminescent compounds, methods, systems and kits utilizing same SUN JI (US) 2005-08-18 — — US disclosed
US-20010018187-A1 Coreactant-including electrochemiluminescent compounds, methods, systems and kits utilizing same IGEN INTERNATIONAL, INC. 2001-08-30 — — US disclosed
US-20010003647-A1 COREATANT-INCLUDING ELECTROCHEMILUMINESCENT COMPOUNDS, METHODS, SYSTEMS AND KITS UTILIZING SAME BIOVERIS CORPORATION 2001-06-14 — — US disclosed
WO-1999015694-A1 COREACTANT-INCLUDING ELECTROCHEMILUMINESCENT COMPOUNDS, METHODS, SYSTEMS AND KITS UTILIZING SAME IGEN INTERNATIONAL, INC. (US) 1999-04-01 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050181443-A1 Coreactant-including electrochemiluminescent compounds, methods, systems and kits utilizing same CETP, LIPG, LIPC MAOA 2648/4885ALDH1A1 967/4885L3MBTL1 3862/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback